IMA Wealth Inc. Has $2.38 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

IMA Wealth Inc. trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 10.7% in the fourth quarter, Holdings Channel.com reports. The firm owned 4,511 shares of the healthcare conglomerate’s stock after selling 539 shares during the period. IMA Wealth Inc.’s holdings in UnitedHealth Group were worth $2,375,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. International Assets Investment Management LLC grew its position in shares of UnitedHealth Group by 53,573.1% during the 4th quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock worth $1,238,515,000 after buying an additional 2,348,107 shares during the period. Jennison Associates LLC grew its position in shares of UnitedHealth Group by 49.3% during the 4th quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock worth $1,904,670,000 after buying an additional 1,195,352 shares during the period. Mawer Investment Management Ltd. lifted its holdings in shares of UnitedHealth Group by 75.0% during the 3rd quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate’s stock valued at $1,014,002,000 after purchasing an additional 862,024 shares in the last quarter. California Public Employees Retirement System lifted its holdings in shares of UnitedHealth Group by 35.9% during the 4th quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock valued at $1,627,311,000 after purchasing an additional 815,822 shares in the last quarter. Finally, Ameriprise Financial Inc. lifted its holdings in shares of UnitedHealth Group by 20.1% during the 3rd quarter. Ameriprise Financial Inc. now owns 3,725,650 shares of the healthcare conglomerate’s stock valued at $1,879,245,000 after purchasing an additional 623,631 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE UNH traded up $1.49 on Friday, reaching $495.35. The stock had a trading volume of 2,727,016 shares, compared to its average volume of 5,623,667. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The firm has a fifty day moving average of $485.84 and a two-hundred day moving average of $514.21. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The company has a market cap of $455.76 billion, a P/E ratio of 30.28, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the prior year, the firm posted $6.26 EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s payout ratio is 45.97%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective on the stock in a report on Thursday, April 4th. Truist Financial restated a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Morgan Stanley cut their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Four research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $570.05.

Insider Buying and Selling

In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the SEC, which is available through this link. In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.